Logo image of ALK.MI

ALKEMY SPA (ALK.MI) Stock Fundamental Analysis

BIT:ALK - Euronext Milan - IT0005314635 - Common Stock - Currency: EUR

12  +0.05 (+0.42%)

Fundamental Rating

3

Overall ALK gets a fundamental rating of 3 out of 10. We evaluated ALK against 33 industry peers in the Professional Services industry. ALK may be in some trouble as it scores bad on both profitability and health. ALK has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ALK had negative earnings in the past year.
ALK had a positive operating cash flow in the past year.
Of the past 5 years ALK 4 years were profitable.
Each year in the past 5 years ALK had a positive operating cash flow.
ALK.MI Yearly Net Income VS EBIT VS OCF VS FCFALK.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

ALK has a worse Return On Assets (-14.54%) than 90.91% of its industry peers.
With a Return On Equity value of -46.87%, ALK is not doing good in the industry: 90.91% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -14.54%
ROE -46.87%
ROIC N/A
ROA(3y)-2.01%
ROA(5y)-0.01%
ROE(3y)-8.29%
ROE(5y)-1.48%
ROIC(3y)N/A
ROIC(5y)N/A
ALK.MI Yearly ROA, ROE, ROICALK.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30 -40

1.3 Margins

In the last couple of years the Operating Margin of ALK has declined.
ALK has a Gross Margin of 53.53%. This is comparable to the rest of the industry: ALK outperforms 42.42% of its industry peers.
In the last couple of years the Gross Margin of ALK has grown nicely.
ALK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.53%
OM growth 3Y-37.63%
OM growth 5Y-2.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.47%
GM growth 5Y7.25%
ALK.MI Yearly Profit, Operating, Gross MarginsALK.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

2

2. Health

2.1 Basic Checks

ALK does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALK has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALK has more shares outstanding
ALK has a worse debt/assets ratio than last year.
ALK.MI Yearly Shares OutstandingALK.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
ALK.MI Yearly Total Debt VS Total AssetsALK.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of 1.76, we must say that ALK is in the distress zone and has some risk of bankruptcy.
ALK has a Altman-Z score of 1.76. This is in the lower half of the industry: ALK underperforms 72.73% of its industry peers.
ALK has a debt to FCF ratio of 6.79. This is a slightly negative value and a sign of low solvency as ALK would need 6.79 years to pay back of all of its debts.
ALK's Debt to FCF ratio of 6.79 is on the low side compared to the rest of the industry. ALK is outperformed by 63.64% of its industry peers.
ALK has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
ALK has a better Debt to Equity ratio (0.44) than 60.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 6.79
Altman-Z 1.76
ROIC/WACCN/A
WACC6.74%
ALK.MI Yearly LT Debt VS Equity VS FCFALK.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

ALK has a Current Ratio of 1.16. This is a normal value and indicates that ALK is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.16, ALK is in line with its industry, outperforming 48.48% of the companies in the same industry.
A Quick Ratio of 1.16 indicates that ALK should not have too much problems paying its short term obligations.
ALK has a Quick ratio of 1.16. This is comparable to the rest of the industry: ALK outperforms 54.55% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
ALK.MI Yearly Current Assets VS Current LiabilitesALK.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

4

3. Growth

3.1 Past

ALK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -619.18%.
Looking at the last year, ALK shows a decrease in Revenue. The Revenue has decreased by -3.60% in the last year.
The Revenue has been growing slightly by 6.61% on average over the past years.
EPS 1Y (TTM)-619.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-445.2%
Revenue 1Y (TTM)-3.6%
Revenue growth 3Y6.02%
Revenue growth 5Y6.61%
Sales Q2Q%-1.68%

3.2 Future

ALK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 150.00% yearly.
Based on estimates for the next years, ALK will show a quite strong growth in Revenue. The Revenue will grow by 10.32% on average per year.
EPS Next Y478.57%
EPS Next 2Y150%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year14.75%
Revenue Next 2Y10.32%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALK.MI Yearly Revenue VS EstimatesALK.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M
ALK.MI Yearly EPS VS EstimatesALK.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 1

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

ALK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 9.98 indicates a reasonable valuation of ALK.
84.85% of the companies in the same industry are more expensive than ALK, based on the Price/Forward Earnings ratio.
ALK is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 9.98
ALK.MI Price Earnings VS Forward Price EarningsALK.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

ALK's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 17.58
EV/EBITDA N/A
ALK.MI Per share dataALK.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

ALK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALK's earnings are expected to grow with 150.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y150%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALKEMY SPA

BIT:ALK (7/9/2025, 7:00:00 PM)

12

+0.05 (+0.42%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.14%
Inst Owner ChangeN/A
Ins Owners19.66%
Ins Owner ChangeN/A
Market Cap69.48M
Analysts45.71
Price Target10.91 (-9.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.73%
PT rev (3m)-5.73%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.98
P/S 0.62
P/FCF 17.58
P/OCF 9.59
P/B 2.07
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.85
EYN/A
EPS(NY)1.2
Fwd EY10.02%
FCF(TTM)0.68
FCFY5.69%
OCF(TTM)1.25
OCFY10.42%
SpS19.26
BVpS5.81
TBVpS-2.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.54%
ROE -46.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.53%
FCFM 3.54%
ROA(3y)-2.01%
ROA(5y)-0.01%
ROE(3y)-8.29%
ROE(5y)-1.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.45%
ROCE(5y)8.95%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-37.63%
OM growth 5Y-2.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.47%
GM growth 5Y7.25%
F-Score3
Asset Turnover1.03
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 6.79
Debt/EBITDA N/A
Cap/Depr 74.51%
Cap/Sales 2.95%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z 1.76
F-Score3
WACC6.74%
ROIC/WACCN/A
Cap/Depr(3y)64.4%
Cap/Depr(5y)58.47%
Cap/Sales(3y)2.28%
Cap/Sales(5y)1.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-619.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-445.2%
EPS Next Y478.57%
EPS Next 2Y150%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.6%
Revenue growth 3Y6.02%
Revenue growth 5Y6.61%
Sales Q2Q%-1.68%
Revenue Next Year14.75%
Revenue Next 2Y10.32%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-236.16%
EBIT growth 3Y-33.87%
EBIT growth 5Y4.11%
EBIT Next Year318.23%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y7649.02%
FCF growth 3Y11.34%
FCF growth 5Y47.84%
OCF growth 1Y196.97%
OCF growth 3Y12.54%
OCF growth 5Y44.99%